期刊文献+

独活寄生汤调节炎性因子表达干预类风湿关节炎患者骨破坏的作用机制 被引量:14

Action Mechanism of Duhuo Jisheng Decoction Intervening Bone Destruction in Patients with RA by Regulating Expressions of Inflammatory Factors
下载PDF
导出
摘要 目的:观察独活寄生汤治疗肝肾不足寒湿痹阻型RA患者的临床疗效,揭示其通过控制炎性细胞因子表达干预骨破坏的作用机制。方法:完成随访的48例肝肾不足寒湿痹阻型RA患者随机分为治疗组和对照组各24例,对照组给予西医常规治疗,治疗组在此基础上加用独活寄生汤散剂口服,疗程24周。记录治疗前后两组患者的DAS28评分、HAQ评分、VAS评分、Sharp评分,测定CRP、ESR的水平,ELISA检测血清IL-17、IL-6、IL-1β、TNF-α、RANKL、OPG的表达水平。结果:(1)两组患者疗后DAS28评分、HAQ评分、VAS评分明显改善,Sharp总分进展速率明显减慢,且治疗组优于对照组(P<0.05或P<0.01)。(2)两组疗后TNF-α、IL-1β、IL-6、IL-17水平都较疗前降低且治疗组优于对照组(P<0.05)。(3)两组疗后RANKL的水平都较疗前降低,OPG、OPG/RANKL升高,且治疗组优于对照组(P<0.05)。结论:独活寄生汤联合西药常规治疗可以有效改善RA患者的临床症状,其机制是通过下调炎性因子的表达,影响OPG/RANKL的水平,抑制破骨细胞活性改善骨破坏。 Objective:To observe the clinical effect of Duhuo Jisheng Decoction in treating RA patients with deficiency of Liver and Kidney and cold dampness impediment,and to reveal the intervening mechanism in bone destruction by controlling the expressions of inflammatory cytokines.Methods:48 cases of RA met the inclusion criteria were randomly divided into the treatment group(n=24)and the control group(n=24).The control group was treated with routine western medication;on which basis,the treatment group was also treated with Duhuo Jisheng Decoction.The treatment duration was 24 weeks.VAS scores,HAQ scores,DAS28 scores and Sharp scores were recorded before and after the treatment in the two groups.The CRP was measured by scattering turbidimetry,ESR was detected by Westergren method,and the expression levels of IL-17,IL-6,IL-1β,TNF-α,RANKL and OPG were detected by ELISA method.Results:The DAS28 scores,HAQ scores and VAS scores were significantly improved,and the total progression rate of Sharp slowed down significantly after the treatment in the two groups(P<0.05,P<0.01);of which the improvements in the treatment group were more significant(P<0.05,P<0.01).The levels of TNF-α,IL-β,IL-6 and IL-17 decreased significantly after the treatment in the two groups(P<0.01),and the decreases in the treatment group were more significant(P<0.05,P<0.01).The RANKL level decreased,the levels of OPG and OPG/RANKL increased significantly after the treatment in the two groups(P<0.01);of which the improvements in the treatment group were more significant(P<0.05).Conclusion:Duhuo Jisheng Decoction combined with routine western medication can effectively improve the clinical symptoms and improve bone destruction of the RA patients.The mechanism is to reduce the expression levels of inflammatory cytokines,influence the level of OPG/RANKL and inhibit the activity of osteoclast.
作者 赵海燕 杜旭 徐慧先 张鸿婷 ZHAO Haiyan;DU Xu;XU Huixian;ZHANG Hongting(The Second Affiliated Hospital of Heilongjiang Unioersity of Chinese Medicine,Harbin 150001,China;Heilongjiang General Hospital of General Bureau of Agricultural Reclamation,Harbin 150088,China;Harbin Hospital of Traditional Chinese Medicine,Harbin 150070,China)
出处 《中医药学报》 CAS 2021年第1期44-48,共5页 Acta Chinese Medicine and Pharmacology
基金 哈尔滨市科技创新人才研究专项资金项目(2016RAQXJ171) 黑龙江省中医药管理局中医药科研课题(ZHY18-090) 黑龙江省博士后科研基金(LBH-Z15212)。
关键词 独活寄生汤 类风湿关节炎 OPG/RANKL 骨破坏 Duhuo Jisheng Decoction Rheumatoid arthritis OPG/RANKL Bone destruction
  • 相关文献

参考文献2

二级参考文献47

  • 1敖雪仁,陈春雪,曾慧妍,廖世煌.清痹洗方熏洗对类风湿性关节炎热痹证临床疗效的影响[J].广州中医药大学学报,2005,22(6):436-439. 被引量:12
  • 2姜泉,焦娟.清热活血法外治类风湿关节炎疗效观察[J].中医正骨,2006,18(3):21-22. 被引量:15
  • 3栗占国.风湿性疾病的规范化治疗势在必行[J].北京大学学报(医学版),2006,38(4):341-344. 被引量:6
  • 4胡永芳,程清琳.中药熏蒸治疗类风湿关节炎的护理[J].河北中医,2006,28(11):863-863. 被引量:3
  • 5姜泉,蒋红,曹炜,焦娟.475例类风湿关节炎患者中医临床证候分析[J].中医杂志,2007,48(3):253-255. 被引量:141
  • 6Grigor C,Capeli H,Stiding A,et al.Effect of a treatment strategy of fight control for rheumatoid arthritis (The TICORA study):a single-blind randomized controlled trial.Lancet,2004,364:263-269.
  • 7Saag KG,Teng GG,Patkar NM,et al.American College of Rheumatology.American College of Rheumatology 2008 recommendations for the use of nonbiologie and biologic diseasemodifying antirheumatie drugs in rheumatoid arthritis.Arthritis Rheum,2008,59:726-784.
  • 8Rantalaiho V,Korpela M,Hannonen P,et al.FIN-RACo Trial Group.The good initial response to therapy with a combination of traditional disease-modifying antirheumatie drugs is sustained over time:the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.Arthritis Rheum,2009,60:1222-1231.
  • 9Choy EH,Smith C,DoréCJ,et al.A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal.Rheumatology,2005,44:1414-1421.
  • 10Visser K,Katehamart W,Loza E,et al.Multinational evidencebased recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis:integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiation.Ann Rheum Dis,2009,58:1086-1093.

共引文献63

同被引文献201

引证文献14

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部